Mutual of America Capital Management LLC Sells 208 Shares of Waters Corporation (NYSE:WAT)

Mutual of America Capital Management LLC reduced its stake in Waters Corporation (NYSE:WAT) by 2.9% in the first quarter, Holdings Channel.com reports. The fund owned 6,895 shares of the medical instruments supplier’s stock after selling 208 shares during the period. Mutual of America Capital Management LLC’s holdings in Waters were worth $2,541,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently made changes to their positions in WAT. Brighton Jones LLC boosted its holdings in shares of Waters by 112.9% in the fourth quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock worth $471,000 after acquiring an additional 673 shares during the period. Avantax Advisory Services Inc. boosted its holdings in shares of Waters by 12.2% in the fourth quarter. Avantax Advisory Services Inc. now owns 1,114 shares of the medical instruments supplier’s stock worth $413,000 after acquiring an additional 121 shares during the period. Envestnet Portfolio Solutions Inc. boosted its holdings in shares of Waters by 15.5% in the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 3,587 shares of the medical instruments supplier’s stock worth $1,331,000 after acquiring an additional 482 shares during the period. Cibc World Markets Corp boosted its holdings in shares of Waters by 16.3% in the fourth quarter. Cibc World Markets Corp now owns 9,373 shares of the medical instruments supplier’s stock worth $3,477,000 after acquiring an additional 1,317 shares during the period. Finally, Parallel Advisors LLC boosted its holdings in shares of Waters by 18.9% in the fourth quarter. Parallel Advisors LLC now owns 856 shares of the medical instruments supplier’s stock worth $318,000 after acquiring an additional 136 shares during the period. 94.01% of the stock is owned by institutional investors.

Waters Trading Down 3.2%

NYSE WAT opened at $287.39 on Friday. The stock’s 50-day simple moving average is $344.45 and its two-hundred day simple moving average is $360.92. Waters Corporation has a twelve month low of $284.65 and a twelve month high of $423.56. The company has a quick ratio of 1.28, a current ratio of 1.81 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $17.10 billion, a price-to-earnings ratio of 26.08, a PEG ratio of 2.93 and a beta of 1.10.

Waters (NYSE:WAT) last released its quarterly earnings results on Tuesday, May 6th. The medical instruments supplier reported $2.25 earnings per share for the quarter, beating analysts’ consensus estimates of $2.22 by $0.03. Waters had a return on equity of 41.70% and a net margin of 22.02%. The business had revenue of $661.71 million for the quarter, compared to the consensus estimate of $655.50 million. During the same quarter last year, the business posted $2.21 earnings per share. The company’s revenue for the quarter was up 3.9% on a year-over-year basis. Research analysts forecast that Waters Corporation will post 12.86 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on WAT shares. Baird R W raised Waters from a “hold” rating to a “strong-buy” rating in a report on Wednesday, March 26th. Sanford C. Bernstein set a $400.00 price objective on Waters and gave the stock an “outperform” rating in a research report on Wednesday, April 16th. UBS Group reiterated a “neutral” rating on shares of Waters in a research report on Tuesday. Robert W. Baird lowered their price objective on Waters from $374.00 to $352.00 and set an “outperform” rating on the stock in a research report on Wednesday. Finally, Jefferies Financial Group reiterated a “buy” rating on shares of Waters in a research report on Monday. Ten analysts have rated the stock with a hold rating, seven have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $381.94.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.